U. Brennscheidt

Results of a phase III trial of erlotinib (OSI-774) combined with cisplatin and gemcitabine (GC) chemotherapy in advanced non-small cell lung cancer (NSCLC)

U. Gatzemeier, A Płużańska, A. Szczęsna et al. · Journal of Clinical Oncology · 2004 · 300 citations

Advanced Nsclc, Oncology, Medicine +14

Exploratory analyses EGFR, kRAS mutations and other molecular markers in tumors of NSCLC patients (pts) treated with chemotherapy +/- erlotinib (TALENT)

U. Gatzemeier, Adi Heller, Dorothee Foernzler et al. · Journal of Clinical Oncology · 2005 · 41 citations

Pathology, Chemotherapy +/- Erlotinib, Tumor Biology +17

Induction of tumor-specific cytotoxic T lymphocytes by immunization with autologous tumor cells and interleukin-2 gene transfected fibroblasts

Andréas Mackensen, Hendrik Veelken, Michael Lahn et al. · Journal of Molecular Medicine · 1997 · 38 citations

Tumor Immunology, Cancer Immunosurveillance, Autoimmune Disease +11

Palmar fibromatosis (Dupuytren's contracture)

Hiroshi Iwasaki, Harald E. M�ller, U. Brennscheidt · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 1984 · 37 citations

Fibrosis, Surgical Pathology, Histopathology +6

A phase Ib dose-escalation study of erlotinib, capecitabine and oxaliplatin in metastatic colorectal cancer patients

Eric Van Cutsem, Chris Verslype, Philip Beale et al. · Annals of Oncology · 2007 · 36 citations

Gastrointestinal Oncology, Medicine, Pharmacology +5